Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: An overview

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 377-383

  Floré, Katelijne M J ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

GDH PQQ; Hyperglycemia; Icodextrin; Maltose; Point of care testing

Indexed keywords

AMYLASE; GLUCOSE; GLUCOSE DEHYDROGENASE; GLUCOSE POLYMER; ICODEXTRIN; MALTOSE; PYRROLOQUINOLINEQUINONE;

BLOOD GLUCOSE MONITORING; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTERMETHOD COMPARISON; METABOLITE; PERITONEAL DIALYSIS; PIONT OF CARE GLUCOMETER; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRAFILTRATION;

EID: 70349495829     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900403     Document Type: Review

References (52)

1. Wolfson M, Piraino B, Hamburger RJ, Morton R. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
2. Wolfson M, Ogrinc F, Mujais S. Review of clinical trial experience with icodextrin. Kidney Int Suppl 2002; 81: S46-52.
3. Garcia-Lopez E, Lindholm B, Tranaeus A. Biocompatibility of new peritoneal dialysis solutions: clinical experience. Perit Dial Int 2000; 20(Suppl 5):S48-56.
4. Mortier S, Faict D, Schalwijk CG, Lameire NH, De Vriese AS. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004; 66:1257-65.
5. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int 2000; 20(Suppl 2):S106-13.
6. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14(Suppl 3):S158-61.
7. Jeloka TK, Ersoy FF, Yavuz M, Sahu KM, Camsari T, Utas C, et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int 2006; 26:336-40.
8. Krediet R, Mujais S. Use of icodextrin in high transport ultrafiltration failure. Kidney Int Suppl 2002; 81:S53-61.
9. Krediet RT, van Westrhenen R, Zweers MM, Struijk DG. Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant 2002; 17(Suppl 3):S16-18.
10. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14:1530-5.
11. Riley SG, Chess J, Donovan KL, Williams JD. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid. BMJ 2003; 327:608-9.
12. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isomolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496-503.
13. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, et al. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 2007; 27:409-15.
14. Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21:275-81.
15. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
16. Canbakan M, Sahin GM. Icodextrin and insulin resistance in continuous ambulatory peritoneal dialysis patients. Ren Fail 2007; 29:289-93.
17. Gürsu EM, Ozdemir A, Yalinbas B, Gürsu RU, Canbakan M, Güven B, et al. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients. Clin Nephrol 2006; 66:263-8.
18. Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods [Letter]. Clin Chem 1998; 44:2379-80.
19. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: S23-33.
20. Wang R, Skoufos L, Martis L. Glucose monitoring for diabetic patients using icodextrin. Perit Dial Int 2004; 24: 296-7.
21. Davies DS. Kinetics of icodextrin. Perit Dial Int 1994; 14(Suppl 2):S45-50.
22. Garcia-Lopez E, Anderstam B, Heimbürger O, Amici G, Werynski A, Lindholm B. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients. Perit Dial Int 2005; 25:181-91.
23. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
24. D'Costa EJ, Higgins IJ, Turner APF. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. Biosensors 1986; 2:71-87.
25. Duine JA. Quinoproteins: enzymes containing the quinonoid cofactor pyrroloquinoline quinone, topaquinone or tryptophan-tryptophan quinone. Eur J Biochem 1991; 200:271-84.
26. Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007; 27:1313-21.
27. Gaines AR, Pierce LR, Bernhardt PA. Fatal iatrogenic hypoglycemia: falsely elevated blood glucose readings with a point-of-care meter due to a maltose-containing intravenous immune globulin product. Available at: http://www.fda.gov/cber/safety/glucfalse.htm
28. Wens R, Taminne M, Devriendt J, Collart F, Broeders N, Mestrez F, et al. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int 1998; 18:603-9.
29. Wang XG, Britton KL, Stillman TJ, Rice DW, Engel PC. Conversion of a glutamate dehydrogenase into methionine/ norleucine dehydrogenase by site-directed mutagenesis. Eur J Biochem 2001; 268:5791-9.
30. Hoenes J, Unkrig V. Method for the colorimetric determination of an analyte with PQQ-dependent dehydrogenase. US Patent 5484708.
31. Duine JA, Jongejan JA. Quinoproteins, enzymes with pyrrolo-quinoline quinone as cofactor. Annu Rev Biochem 1989; 58:403-26.
32. Olsthoorn AJ, Duine JA. Production, characterization, and reconstitution of recombinant quinoprotein glucose dehydrogenase (soluble type; EC1.1.99.17) apoenzyme of Acinetobacter calcoaceticus. Arch Biochem Biophys 1996; 336:42-8.
33. Igarashi S, Ohtera T, Yoshida H, Witarto AB, Sode K. Construction and characterization of mutant water-soluble PDD glucose dehydrogenase with altered K(m) values-site-directed mutagenesis studies on the putative active site. Biochem Biophys Res Commun 1999; 264:820-4.
34. Dokter P, Frank J, Duine JA. Purification and characterization of quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus L.M.D.79.41. Biochem J 1986; 239:163-8.
35. http://www.octapharma.com/USA/documents/ FINAL%20Maltose%20WARNING%20Letter%2019-10-5.pdf
36. Floré K, Delanghe JR. Icodextrin: a major problem for glucose dehydrogenase-based glucose point of care testing systems. Acta Clin Belg 2006; 61:351-4.
37. de Waart DR, Zweers MM, Struijk DG, Krediet RT. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21:269-74.
38. Slim S, Griffiths MJ, Gama R. Icodextrin still a cause for concern with blood glucose monitoring in continuous ambulatory peritoneal dialysis patients with diabetes [Letter]. Ann Clin Biochem 2007; 44:196-7.
39. Grzegorzewska AE, Antczak-Jedrzejczak D, Mariak I. Polyglucose dialysis solution influences serum activity of amylase and of lipase differently. Adv Perit Dial 2000; 16: 113-18.
40. Schoenicke G, Grabensee B, Plum J. Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant 2002; 17:1988-92.
41. Anderstam B, Garcia-Lopez E, Heimburger O, Lindholm B. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid. Perit Dial Int 2003; 23:146-50.
42. Wang R, Leesch V, Turner P, Moberly JB, Martis L. Kinetic analysis of icodextrin interference with serum amylase assays. Adv Perit Dial 2002; 18:96-9.
43. Mistry CD, Gokal R. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month study. Nephrol Dial Transplant 1993; 8:443-7.
44. Garcia-Lopez E, Werynski A, Heimbürger O, Filho JC, Lindholm B, Anderstam B. Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients. Perit Dial Int 2008; 28: 296-304.
45. FDA. Important Safety Information on Interference with Blood Glucose Measurement Following Use of Parenteral Maltose/Parenteral Galactose/ Oral Xylose-Containing Products. 9 November 2005. Available at: www.fda.gov/cber/safety/maltose110405.htm
46. Lage C. Effect of icodextrin on laboratory measurements. PDServe.Connection 2004; 8(2):1-3. Available at: http://www.pdserve.com/pdserve/pdserve.nsf/Content/PDServe+Connection
47. Accu-Chek Comfort Curve Test Strips [package insert]. Indianapolis, IN: Roche Diagnostics; 2004.
48. Roche Diagnostics Corporation. Safety Alert [ACCU-CHEK Blood Glucose Monitoring Systems - Reminder of Potential for Falsely Elevated Blood Glucose Readings due to Drug Interferences], September 7, 2006. Available at: http://www.accuchek.com/en_US/pdf/06_205POC_ MaltoseSafetyAlert.pdf
49. Mehmet S, Quan G, Thomas S, Goldsmith D. Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis. Diabet Med 2001; 18:679-82.
50. Disse E, Thivolet C. Hypoglycaemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements [Letter]. Diabetes Care 2004; 27:2279.
51. Hoftman N. Interference between Extraneal peritoneal dialysis and the Accu-Chek blood glucose monitor [Letter]. Anesthesiology 2005; 102:871.
52. Lau C, Borgmann S, Maciejewska M, Ngounou B, Gründler P, Schuhmann W. Improved specificity of reagentless amperometric PQQ-sGDH glucose biosensors by using indirectly heated electrodes. Biosens Bioelectron 2007; 22: 3014-20.